PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Telmisartan
Presentation Product Chemical substance Chapter Items dispensed
Telmisartan 40mg tablets
0205052Q0AAAAAA
Telmisartan Telmisartan Cardiovascular System 38,307
Telmisartan 80mg tablets
0205052Q0AAABAB
Telmisartan Telmisartan Cardiovascular System 36,799
Telmisartan 20mg tablets
0205052Q0AAACAC
Telmisartan Telmisartan Cardiovascular System 19,145
Micardis 80mg tablets
0205052Q0BBABAB
Micardis Telmisartan Cardiovascular System 858
Micardis 40mg tablets
0205052Q0BBAAAA
Micardis Telmisartan Cardiovascular System 841
Micardis 20mg tablets
0205052Q0BBACAC
Micardis Telmisartan Cardiovascular System 193
Telmisartan 40mg/5ml oral suspension
0205052Q0AAADAD
Telmisartan Telmisartan Cardiovascular System No data available
Tolura 20mg tablets
0205052Q0BCACAC
Tolura Telmisartan Cardiovascular System No data available
Tolura 40mg tablets
0205052Q0BCAAAA
Tolura Telmisartan Cardiovascular System No data available
Tolura 80mg tablets
0205052Q0BCABAB
Tolura Telmisartan Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.